Kumar Vinit, Toffoli Giuseppe, Rizzolio Flavio
Department of Translational Research National Cancer Institute-CRO , Via Franco Gallini 2, Aviano 33081, Italy.
ACS Med Chem Lett. 2013 Oct 24;4(11):1012-3. doi: 10.1021/ml400394a. eCollection 2013 Nov 14.
Nanotechnology provides exciting opportunities for the development of novel, clinically relevant diagnostic and therapeutic multifunctional systems. Fluorescent carbon nanoparticles (CNPs) due to their intrinsic fluorescence and high biocompatibility are among the best candidates. As innovative nanomaterials, CNPs could be utilized both as nontoxic drug delivery system and bioimaging. We foresee a great future for CNPs in cancer diagnostic and therapy.
纳米技术为新型临床相关诊断和治疗多功能系统的开发提供了令人兴奋的机遇。荧光碳纳米颗粒（CNPs）因其固有的荧光特性和高生物相容性，是最佳候选材料之一。作为创新的纳米材料，CNPs既可以用作无毒药物递送系统，也可以用于生物成像。我们预见CNPs在癌症诊断和治疗方面有着广阔的前景。
